Clinical Trials in Tennessee

Showing 16681-16700 of 17,345 trials

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

NCT00294866

Studies have shown that patients with ESRD on hemodialysis have high levels of inflammatory markers which may contribute to the high rates of cardiovascular disease and mortality seen in these patients. Vitamin D use in dialysis patients has been shown to have a survival benefit, with paricalcitol at advantage over calcitriol. Since there is some evidence for involvement of the vitamin D receptor in inflammation, this study is designed to look for an effect of paricalcitol on markers of inflammation in hemodialysis patients.

Kidney Failure

Fresenius Medical Care North America64 participantsStarted Mar 2006

Evergreen Park, Illinois, United States • Kalamazoo, Michigan, United States • West Orange, New Jersey, United States +3 more locations

COMPLETEDPhase 229 miles

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

NCT01083875

The purpose of this study was to determine the effect of 0.5% amlexanox oral rinse compared to a vehicle control on mucositis-related ulceration and erythema (objective score)and on mucositis-related oral pain (subjective score). A secondary objective was to evaluate the safety of 0.5% amlexanox oral rinse by determining the frequency of treatment-emergent drug-related adverse events or clinical laboratory abnormalities.

Oral Mucositis

Access Pharmaceuticals, Inc.58 participantsStarted Feb 2000

Mobile, Alabama, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +9 more locations

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Find Trials by Condition in Tennessee

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Diabetes Control and Complications Trial (DCCT)

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Herpetic Eye Disease Study (HEDS) II

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia